Now Available:
Watch video podcasts of the 2008 EULAR press conferences

CME Opportunity:

Bones: Zoledronic Acid Prevents Chemo-Induced Bone Loss in Premenopausal Women With Breast Cancer
As the population of breast cancer survivors grows, the risks of life after cancer treatment are becoming a major concern. One risk is bone loss caused by chemotherapy, and phase III data show that a dose of zoledronic acid every 3 months during chemotherapy can prevent this problem in premenopausal women with breast cancer....

Consumer News: Wrinkle Removers, Backed by Science
Scientific evidence has emerged that three anti-aging treatments are clinically effective: topical application of retinol, carbon dioxide resurfacing, and injection of hyaluronic acid...

BioPharm Business: Mesoblast Reports Stem Cells Regrow Knee Cartilage in Postmenopausal Ewes With OA; Repair Nonhealing Bones in Humans
Mesoblast, a regenerative medicine company developing treatments for orthopaedic conditions, announced successful preclinical trial results showing that its proprietary adult stem cells regenerated and regrew damaged knee cartilage...

Click here to remove your e-mail address from our mailing list. For questions and comments regarding this newsletter please contact .